BTA 0.00% 57.0¢ biota holdings limited

iv relenza gsk pipeline

  1. cpg
    3,625 Posts.
    According to this GSK report. Relenza is a pipeline product.

    ''Product Development Pipeline''
    February 2006

    This document outlines GlaxoSmithKline’s drug development
    portfolio. The content of the portfolio will change over time
    as new compounds progress from research to development
    and from development to the market.
    Owing to the nature of the drug development process,
    it is not unusual for some compounds, especially those
    in early stages of investigation, to be terminated as they
    progress through development.''

    Product Development Pipeline February 2006

    Phase I Phase II Phase III Filed/Approved

    Relenza†

    Submitted November 2005




    This must be IV relenza what else could it be.

    http://www.gsk.com/investors/product_pipeline/docs/pipeline.pdf
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.